KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Assets (2016 - 2025)

Gilead Sciences' Assets history spans 17 years, with the latest figure at $59.0 billion for Q4 2025.

  • For Q4 2025, Assets changed 0.05% year-over-year to $59.0 billion; the TTM value through Dec 2025 reached $59.0 billion, changed 0.05%, while the annual FY2025 figure was $59.0 billion, 0.05% changed from the prior year.
  • Assets reached $59.0 billion in Q4 2025 per GILD's latest filing, up from $58.5 billion in the prior quarter.
  • In the past five years, Assets ranged from a high of $68.0 billion in Q2 2021 to a low of $53.6 billion in Q2 2024.
  • Average Assets over 5 years is $61.2 billion, with a median of $62.2 billion recorded in 2023.
  • Peak YoY movement for Assets: increased 21.54% in 2021, then fell 14.05% in 2024.
  • A 5-year view of Assets shows it stood at $68.0 billion in 2021, then dropped by 7.04% to $63.2 billion in 2022, then decreased by 1.66% to $62.1 billion in 2023, then fell by 5.04% to $59.0 billion in 2024, then increased by 0.05% to $59.0 billion in 2025.
  • Per Business Quant, the three most recent readings for GILD's Assets are $59.0 billion (Q4 2025), $58.5 billion (Q3 2025), and $55.7 billion (Q2 2025).